InsiderTrades.com logo

REGN Insider Trading

Insider Ownership Percentage: 7.02%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,676,259.59

Regeneron Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Regeneron Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Regeneron Pharmaceuticals Share Price & Price History

Current Price: $732.87
Price Change: ▼ Price Decrease of -4.58 (-0.62%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for REGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Regeneron Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/19/2026Huda Y. ZoghbiDirectorSell1,638$781.33$1,279,818.541,703View SEC Filing Icon  
2/9/2026Arthur F. RyanDirectorSell100$778.53$77,853.0017,803View SEC Filing Icon  
2/9/2026Jason PitofskySVPSell2,036$778.52$1,585,066.724,272View SEC Filing Icon  
1/7/2026Bonnie L. BasslerDirectorSell1,500$800.00$1,200,000.001,703View SEC Filing Icon  
11/7/2025Jason PitofskyVPSell431$651.43$280,766.334,233View SEC Filing Icon  
10/29/2025Christine A. PoonDirectorSell6,500$654.27$4,252,755.002,352View SEC Filing Icon  
8/28/2024Christopher R. FenimoreCFOSell5,680$1,205.33$6,846,274.4015,305View SEC Filing Icon  
8/7/2024Jason PitofskyVPSell487$1,070.00$521,090.004,204View SEC Filing Icon  
7/11/2024Joseph J. LarosaEVPSell1,866$1,088.95$2,031,980.7037,937View SEC Filing Icon  
7/1/2024Arthur F. RyanDirectorSell100$1,059.24$105,924.0017,882View SEC Filing Icon  
7/1/2024Marion MccourtEVPSell1,137$1,047.11$1,190,564.0712,931View SEC Filing Icon  
6/24/2024Bonnie L. BasslerDirectorSell756$1,062.00$802,872.001,382View SEC Filing Icon  
6/14/2024Michael S. BrownDirectorSell1,535$1,040.00$1,596,400.001,382View SEC Filing Icon  
6/11/2024Leonard S. SchleiferCEOSell9,064$1,015.43$9,203,857.5255,134View SEC Filing Icon  
6/6/2024Leonard S. SchleiferCEOSell787$1,015.02$798,820.7464,198View SEC Filing Icon  
6/5/2024Bonnie L. BasslerDirectorSell827$1,011.00$836,097.001,382View SEC Filing Icon  
5/28/2024Michael S. BrownDirectorSell1,172$974.86$1,142,535.921,382View SEC Filing Icon  
5/17/2024Leonard S. SchleiferCEOSell22,830$979.23$22,355,820.90466,877View SEC Filing Icon  
5/14/2024Leonard S. SchleiferCEOSell25,000$979.25$24,481,250.00408,200View SEC Filing Icon  
3/14/2024Andrew J. MurphyEVPSell5,783$956.47$5,531,266.0148,306View SEC Filing Icon  
3/1/2024Arthur F. RyanDirectorSell100$982.05$98,205.0018,282View SEC Filing Icon  
3/1/2024Marion MccourtEVPSell358$967.50$346,365.0013,431View SEC Filing Icon  
2/26/2024Bonnie L. BasslerDirectorSell854$979.25$836,279.501,382View SEC Filing Icon  
2/22/2024Joseph J. LarosaEVPSell1,000$967.65$967,650.0037,543View SEC Filing Icon  
2/7/2024Joseph J. LarosaEVPSell1,000$950.00$950,000.0038,543View SEC Filing Icon  
2/5/2024Marion MccourtEVPSell1,000$934.71$934,710.0013,789View SEC Filing Icon  
2/1/2024Arthur F. RyanDirectorSell100$954.22$95,422.0018,382View SEC Filing Icon  
1/30/2024Bonnie L. BasslerDirectorSell827$959.00$793,093.001,382View SEC Filing Icon  
1/23/2024Joseph L. GoldsteinDirectorSell2,707$950.00$2,571,650.006,382View SEC Filing Icon  
1/2/2024George D. YancopoulosInsiderSell16,848$900.00$15,163,200.00180,000View SEC Filing Icon  
12/27/2023Christopher R. FenimoreSVPSell2,448$856.71$2,097,226.0814,372View SEC Filing Icon  
12/27/2023Michael S. BrownDirectorSell2,049$898.00$1,840,002.001,247View SEC Filing Icon  
12/21/2023Christopher R. FenimoreSVPSell1,680$844.01$1,417,936.8017,070View SEC Filing Icon  
12/1/2023Arthur F. RyanDirectorSell100$817.30$81,730.0018,447View SEC Filing Icon  
11/7/2023Arthur F. RyanDirectorSell100$827.90$82,790.0018,547View SEC Filing Icon  
11/1/2023Marion MccourtEVPSell1,000$783.91$783,910.0019,803View SEC Filing Icon  
10/13/2023Huda Y. ZoghbiDirectorSell1,000$850.00$850,000.001,247View SEC Filing Icon  
10/2/2023Marion MccourtEVPSell1,038$827.00$858,426.0019,803View SEC Filing Icon  
8/24/2023Plew Daniel P VanEVPSell6,197$841.71$5,216,076.8721,508View SEC Filing Icon  
8/23/2023Christine A. PoonDirectorSell12,280$839.97$10,314,831.602,037View SEC Filing Icon  
8/23/2023Robert E. LandryCFOSell223$844.00$188,212.0031,699View SEC Filing Icon  
8/22/2023Neil StahlEVPSell11,665$840.98$9,810,031.7053,100View SEC Filing Icon  
8/21/2023Bonnie L. BasslerDirectorSell853$829.00$707,137.001,247View SEC Filing Icon  
8/10/2023Bonnie L. BasslerDirectorSell853$789.00$673,017.001,247View SEC Filing Icon  
8/1/2023Arthur F. RyanDirectorSell100$736.59$73,659.0018,647View SEC Filing Icon  
7/3/2023Arthur F. RyanDirectorSell100$716.88$71,688.0018,747View SEC Filing Icon  
7/3/2023Marion MccourtEVPSell250$710.09$177,522.5020,303View SEC Filing Icon  
6/1/2023Arthur F. RyanDirectorSell100$735.42$73,542.0018,847View SEC Filing Icon  
6/1/2023Marion MccourtEVPSell250$736.00$184,000.0020,553View SEC Filing Icon  
4/21/2023Michael S. BrownDirectorSell3,070$798.42$2,451,149.401,247View SEC Filing Icon  
4/3/2023Arthur F. RyanDirectorSell100$819.31$81,931.0019,047View SEC Filing Icon  
4/3/2023Marion MccourtEVPSell1,100$818.80$900,680.0020,803View SEC Filing Icon  
3/27/2023Robert E. LandryCFOSell183$821.70$150,371.1032,929View SEC Filing Icon  
3/24/2023Bonnie L. BasslerDirectorSell1,240$818.00$1,014,320.001,247View SEC Filing Icon  
3/23/2023Christopher R. FenimoreSVPSell2,192$806.47$1,767,782.2418,409View SEC Filing Icon  
3/23/2023George D. YancopoulosInsiderSell3,656$804.26$2,940,374.56196,848View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at REGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Regeneron Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Purpose Unlimited Inc.113$87K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.27,053$20.88M0.0%+4.7%0.026%Search for SEC Filing on Google Icon
3/13/2026World Investment Advisors798$0.62M0.0%+56.5%0.001%Search for SEC Filing on Google Icon
3/10/2026PeakShares LLC1,428$1.10M1.1%N/A0.001%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC16,590$12.81M0.0%-4.5%0.016%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC318,808$246.22M0.1%-15.2%0.302%Search for SEC Filing on Google Icon
3/4/2026Pure Financial Advisors LLC497$0.38M0.0%+35.4%0.000%Search for SEC Filing on Google Icon
3/4/2026Rehmann Capital Advisory Group2,371$1.83M0.1%+10.4%0.002%Search for SEC Filing on Google Icon
3/4/2026SHP Wealth Management34$26K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/3/2026Bank of Hawaii1,049$0.81M0.0%+2.5%0.001%Search for SEC Filing on Google Icon
3/2/2026Reflection Asset Management140$0.11M0.1%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Sankala Group LLC65$51K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Tobam498$0.38M0.1%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Wick Capital Partners LLC435$0.34M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/27/2026Groupama Asset Managment71,182$54.94M0.8%+13.5%0.067%Search for SEC Filing on Google Icon
2/26/2026Oak Grove Capital LLC1,730$1.34M0.2%-2.8%0.002%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank298$0.23M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026DGS Capital Management LLC305$0.24M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026SG Trading Solutions LLC3,992$3.08M0.7%N/A0.004%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.397,666$306.95M0.5%-10.7%0.376%Search for SEC Filing on Google Icon
2/23/2026Kera Capital Partners Inc.475$0.35M0.0%-4.8%0.000%Search for SEC Filing on Google Icon
2/23/2026MV Capital Management Inc.78$60K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2026Kovitz Investment Group Partners LLC762$0.59M0.0%-42.1%0.001%Search for SEC Filing on Google Icon
2/20/2026Wick Capital Partners LLC657$0.51M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.1,676$1.29M0.0%+69.3%0.002%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.1,591,105$1.23B0.2%+7.2%1.505%Search for SEC Filing on Google Icon
2/19/2026Birchwood Financial Partners Inc.41$32K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC23,019$17.77M0.0%+32.5%0.022%Search for SEC Filing on Google Icon
2/18/2026Alpine Woods Capital Investors LLC320$0.25M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Ameriflex Group Inc.145$0.11M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV15,136$11.68M0.0%+22.7%0.014%Search for SEC Filing on Google Icon
2/18/2026Summit Global Investments9,822$7.58M0.4%-49.9%0.009%Search for SEC Filing on Google Icon
2/18/2026Blue Chip Partners LLC945$0.73M0.1%+31.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Raymond James Financial Inc.149,610$115.48M0.0%+8.0%0.142%Search for SEC Filing on Google Icon
2/18/2026Papamarkou Wellner Asset Management inc.382$0.30M0.2%+4.7%0.000%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC2,668$2.06M0.0%-0.6%0.003%Search for SEC Filing on Google Icon
2/18/2026Beacon Pointe Advisors LLC12,064$9.31M0.1%-1.2%0.011%Search for SEC Filing on Google Icon
2/18/2026Wahed Invest LLC2,668$2.06M0.3%-6.9%0.003%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury40,136$29.76M0.1%-16.7%0.038%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC1,636$1.26M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp78,736$60.82M0.1%-38.8%0.074%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC9,920$7.66M0.0%+146.0%0.009%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC12,051$9.30M0.7%-23.2%0.011%Search for SEC Filing on Google Icon
2/18/2026Zurich Insurance Group Ltd FI40,812$31.50M0.2%-72.8%0.039%Search for SEC Filing on Google Icon
2/18/2026Utah Retirement Systems17,072$13.18M0.1%-0.9%0.016%Search for SEC Filing on Google Icon
2/18/2026VARCOV Co.2,500$1.93M0.8%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026VestGen Advisors LLC1,650$1.27M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC921$0.71M0.2%+8.1%0.001%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP664,465$512.88M0.2%+8,620.0%0.629%Search for SEC Filing on Google Icon
2/18/2026Tang Capital Management LLC8,000$6.18M0.3%-20.0%0.008%Search for SEC Filing on Google Icon
2/18/2026Toronto Dominion Bank53,958$41.65M0.1%-1.7%0.051%Search for SEC Filing on Google Icon
2/18/2026Summit Securities Group LLC308$0.24M0.0%+1,000.0%0.000%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC935$0.72M0.1%+58.7%0.001%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd27,611$21.31M0.2%-54.8%0.026%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC968$0.75M0.5%N/A0.001%Search for SEC Filing on Google Icon
2/18/2026Man Group plc218,112$168.35M0.3%-19.7%0.206%Search for SEC Filing on Google Icon
2/18/2026IHT Wealth Management LLC593$0.46M0.0%-3.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Investment Management Corp of Ontario9,206$7.11M0.1%+28.6%0.009%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC205,672$158.79M0.1%+178.9%0.195%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC80,271$61.96M0.2%-4.7%0.076%Search for SEC Filing on Google Icon
2/18/2026Evolve Private Wealth LLC2,028$1.57M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP9,607$7.42M0.1%-49.6%0.009%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP10,097$7.79M0.4%-39.6%0.010%Search for SEC Filing on Google Icon
2/18/2026Capitolis Liquid Global Markets LLC80,000$61.75M0.4%+6.7%0.076%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP29,797$23M4.3%-15.7%0.028%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP6,343$4.90M0.3%+227.5%0.006%Search for SEC Filing on Google Icon
2/18/2026Claro Advisors Inc.557$0.43M0.1%+22.4%0.001%Search for SEC Filing on Google Icon
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.36,038$27.83M0.2%-4.2%0.034%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC84,000$64.84M0.8%-32.9%0.079%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP41,409$31.96M0.2%-35.5%0.039%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC44,918$34.67M0.2%+6.2%0.042%Search for SEC Filing on Google Icon
2/17/2026Caisse de depot et placement du Quebec342,319$264.23M0.4%-26.0%0.324%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC12,051$9.30M0.7%-23.2%0.011%Search for SEC Filing on Google Icon
2/17/2026DV Equities LLC142$0.11M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC995,710$768.52M0.4%+38.0%0.947%Search for SEC Filing on Google Icon
2/17/2026GAM Holding AG386$0.30M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026EFG International AG1,885$1.46M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Camarda Financial Advisors LLC2,037$1.57M0.6%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers15,808$12.20M0.0%-1.5%0.015%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC10,838$8.37M0.0%+4.4%0.010%Search for SEC Filing on Google Icon
2/17/2026Equitable Holdings Inc.1,205$0.93M0.0%+43.1%0.001%Search for SEC Filing on Google Icon
2/17/2026Rexford Capital Inc.288$0.22M0.2%+5.5%0.000%Search for SEC Filing on Google Icon
2/17/2026Game Creek Capital LP8,435$6.51M2.2%+71.3%0.008%Search for SEC Filing on Google Icon
2/17/2026Laird Norton Wetherby Trust Company LLC2,738$2.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Kovack Advisors Inc.501$0.39M0.0%+30.8%0.000%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP3,403$2.63M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Amundi791,906$611.25M0.2%+27.4%0.753%Search for SEC Filing on Google Icon
2/17/2026Nearwater Capital Markets Ltd30,000$23.16M0.4%N/A0.029%Search for SEC Filing on Google Icon
2/17/2026iSAM Funds UK Ltd375$0.29M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026FIL Ltd529,190$408.47M0.3%+182.2%0.504%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC1,554$1.20M0.0%-85.4%0.001%Search for SEC Filing on Google Icon
2/17/2026Northern Trust Corp944,933$729.37M0.1%-4.0%0.899%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd13,890$10.75M0.1%+58.3%0.013%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,949,797$1.50B0.2%+142.2%1.855%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP10,100$7.80M0.4%-10.6%0.010%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC105,000$81.05M4.0%+110.0%0.100%Search for SEC Filing on Google Icon
2/17/2026Advisory Services Network LLC3,888$3M0.0%-2.3%0.004%Search for SEC Filing on Google Icon
2/17/2026Harvey Capital Management Inc.10,198$7.87M1.7%-10.6%0.010%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.82,446$63.64M0.1%-33.0%0.078%Search for SEC Filing on Google Icon
2/17/2026Tower Research Capital LLC TRC 6,724$5.19M0.1%+22.0%0.006%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Read More on Regeneron Pharmaceuticals

Today's Range

Now: $732.87
Low: $728.64
High: $744.85

50 Day Range

MA: $765.35
Low: $732.87
High: $803.17

52 Week Range

Now: $732.87
Low: $476.49
High: $821.11

Volume

1,359,874 shs

Average Volume

603,749 shs

Market Capitalization

$77.48 billion

P/E Ratio

17.63

Dividend Yield

0.51%

Beta

0.41

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top insider investors include:
  1. Leonard S Schleifer (CEO)
  2. Joseph J Larosa (EVP)
  3. Arthur F Ryan (Director)
  4. Christopher R Fenimore (CFO)
  5. Marion Mccourt (EVP)
  6. Jason Pitofsky (SVP)
  7. Jason Pitofsky (VP)
  8. Christine A Poon (Director)
  9. Bonnie L Bassler (Director)
  10. Huda Y Zoghbi (Director)
  11. Michael S Brown (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.

Who are the major institutional investors of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 8.63%
  2. State Street Corp — 4.43%
  3. Dodge & Cox — 4.37%
  4. Franklin Resources Inc. — 2.44%
  5. Geode Capital Management LLC — 2.40%
  6. Nuveen LLC — 1.91%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.

Which institutional investors are selling Regeneron Pharmaceuticals stock?

In the previous quarter, REGN stock was sold by these institutional investors:
  1. Capital World Investors
  2. Renaissance Technologies LLC
  3. Assenagon Asset Management S.A.
  4. Bridgewater Associates LP
  5. Bank of Nova Scotia
  6. Caisse de depot et placement du Quebec
  7. Zurich Insurance Group Ltd FI
  8. Jane Street Group LLC
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
  1. Leonard S Schleifer (CEO)
  2. Joseph J Larosa (EVP)
  3. Arthur F Ryan (Director)
  4. Christopher R Fenimore (CFO)
  5. Marion Mccourt (EVP)
  6. Jason Pitofsky (SVP)
Learn More investors selling Regeneron Pharmaceuticals stock.

Which institutional investors are buying Regeneron Pharmaceuticals stock?

During the last quarter, REGN stock was purchased by institutional investors including:
  1. Norges Bank
  2. Price T Rowe Associates Inc. MD
  3. Nuveen LLC
  4. Wellington Management Group LLP
  5. FIL Ltd
  6. AQR Capital Management LLC
  7. Amundi
  8. Robeco Institutional Asset Management B.V.